Golimumab is a new tumour necrosis factor antagonist indicated for the treatment of psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis. Nicholas Thayer describes the drug’s properties and discusses its potential place in the treatment of psoriatic arthritis.

Last year’s market authorisation for 3,4-diaminopyridine phosphate put a drug on the radar that not many pharmacists are likely to encounter in their clinical practice. Annett Blochberger and John Philip O’Dwyer describe the drug’s properties and review the evidence supporting its use in Lambert-Eaton myasthenic syndrome.

Prescribers’ Corner describes situations encountered by pharmacist prescribers and invites you to consider clinical decisions about the patient. In this case, you are managing a patient previously admitted with chest pain who has developed a burning pain in his lower legs and feet. By Magnus Hird.

It is important for pharmacist independent prescribers to understand the licensing system for medicines. This article from the Centre for Pharmacy Postgraduate Education summarises key legislation relating to the medicines regulatory framework. By Christopher Cutts.

Patients involved in local adult mental health services can now be referred to a pharmacist-led medicines management service at St Charles Hospital, London. Caroline Parker and Catherine Duggan describe why and how the clinic was developed.

Poor communication between secondary and primary care can lead to poor continuity of patient care. Celia Villalba-Mendez and Louise Missen describe how new discharge standards that aim to reduce this problem have been tested and put in place in the paediatric pharmacy department at Barts and The London NHS Trust.

Ruth Massey and Gail Cooper are specialist clinical pharmacists working at Ashworth Hospital. In this article, they describe how they provide high quality pharmaceutical care to challenging patients.

How the introduction and development of consultant pharmacist posts support the QIPP agenda was one of the many topics discussed at this year’s Guild of Healthcare Pharmacists and UK Clinical Pharmacy Association joint national conference. Shona Kirk reports.

With new criteria for meeting research standards set to come into play at the next assessment of research quality in UK higher education institutions, Philip Brown asks how well schools and departments of pharmacy will meet the increasingly demanding criteria and gives his opinion on the future of pharmacy education and research.